Prof. David Tougeron

Pr. David Tougeron is a full professor of gastroenterology at Poitiers University Hospital, France. His clinical interests focus on gastrointestinal cancers, in particular dMMR/MSI colorectal cancer. Pr. David Tougeron has participated in more than 190 clinical trials in digestive oncology and has co-authored more than 130 articles, editorials, and book chapters. After a Ph.D. on immune response in colorectal cancer, Pr. Tougeron completed a postdoctoral position at the Mayo Clinic, USA. Pr. David Tougeron is the coordinator of five academic trials, mostly on immuno-oncology in colorectal and gastric cancers (SAMCO NCT03186326, DURIGAST NCT03959293, SIRTCI NCT04659382, POCHI NCT04262687, and OESIRI NCT03719924). Pr. David Tougeron's H index is 32. Pr. David Tougeron's research currently focuses on colorectal cancer, particularly colorectal cancer with microsatellite instability, immune-oncology, and predictive biomarkers of response to targeted therapies and immune checkpoint inhibitors. Pr. David Tougeron presently holds professional positions in different organizations, notably the Fédération Francophone de Cancérologie Digestive (FFCD), as member of the FFCD scientific council, and the PRODIGE group (Partenariat de Recherche en Oncologie DIGEstive), as head of the oesophageal/gastric PRODIGE subgroup. He is also a member of the advisory council of the European Society of Digestive Oncology (ESDO).